/* Если false, то подключаем файлы шрифтов, если true - грузим base64 в localstorage */?>
Due to certain genetic factors, hormone replacement therapy may increase the risk of thrombosis or breast cancer in 5-10% of women.
Our genes predispose us to the development of certain diseases. Knowing this and following relevant recommendations, these risks can be minimized. Our FEMgens profile informs you of potential risks and personalises treatment.
CAUSES OF BREAST CANCER
5-10% hereditary
15-20% family
70-80% sporadic
RISK FACTORS
- Family history
- Obesity, high-calorie diet
- Smoking, drinking, lack of physical activity
- Hormone replacement therapy (HRT)
During menopause, women produce less estrogen, which leads to more or less pronounced symptoms, including hot flashes, sweating, insomnia, anxiety and vaginal dryness.
To prevent these disorders, hormone replacement therapy should be prescribed to compensate for the reduced level of hormones.
HORMONE REPLACEMENT THERAPY — PROS AND CONS
PROS:
Better quality of life
Better skin condition
Reduced risk of senile dementia
Prevention of osteoporosis
Reduced bowel cancer risk
Reduced risk of Alzheimer's disease
CONS:
Risk of venous thrombosis
Risk of breast cancer
The results of a FEMgens profile test show the risk of thrombosis or breast cancer when using hormone replacement therapy. It also helps to customise HRT treatment, individually fine-tuning the doses of hormones and evaluating the effectiveness of pharmacological alternatives for each individual patient.
Your genes are unique. Genomic medicine reveals why everyone is different from each other and have their own characteristics that make each individual person distinct. The traits determined by genes can be changed through eating habits and individual lifestyles. The study of DNA enables us to make an individual prognosis and prevent diseases.
Learn more about our programmes and make an appointment with a specialist